Literature DB >> 3409030

Autoradiographic analysis of [3H]desmethylimipramine binding in the human brain postmortem.

R Gross-Isseroff1, M Israeli, A Biegon.   

Abstract

In vitro quantitative autoradiography of high-affinity [3H]desmethylimipramine (DMI) binding sites was performed on 24 human brains postmortem. Highest densities of binding sites were found in portions of the amygdala, the granular layer of the dentate gyrus, the pyramidal layer of CA4. Next, in descending order were other portions of the hippocampus and amygdala, the head of the caudate nucleus, putamen, hypothalamus, insular cortex, prefrontal cortex, parietal, frontal and temporal cortex, anterior, medial and posterolateral nuclei of the thalamus. Lowest densities, hardly above background, were found in the two divisions of the globus pallidus, the centromedian, ventrolateral and posteroventral lateral nuclei of the thalamus, substantia nigra, red nucleus and white matter. Specific high-affinity [3H]DMI binding was not affected by age, sex and suicide in any of the regions studied. It was negatively correlated with postmortem delay in several regions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409030     DOI: 10.1016/0006-8993(88)90353-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.

Authors:  Magnus Schou; Judit Sóvágó; Victor W Pike; Balázs Gulyás; Klaus P Bøgesø; Lars Farde; Christer Halldin
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488

2.  Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei.

Authors:  G A Ordway; C A Stockmeier; G W Cason; V Klimek
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

3.  Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.

Authors:  Nicholas Seneca; Balázs Gulyás; Andrea Varrone; Magnus Schou; Anu Airaksinen; Johannes Tauscher; Francois Vandenhende; William Kielbasa; Lars Farde; Robert B Innis; Christer Halldin
Journal:  Psychopharmacology (Berl)       Date:  2006-08-04       Impact factor: 4.530

Review 4.  Ovarian steroids and serotonin neural function.

Authors:  C L Bethea; M Pecins-Thompson; W E Schutzer; C Gundlah; Z N Lu
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

Review 5.  The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.

Authors:  J N Joyce
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.

Authors:  Fanxing Zeng; Jiyoung Mun; Nachwa Jarkas; Jeffrey S Stehouwer; Ronald J Voll; Gilles D Tamagnan; Leonard Howell; John R Votaw; Clinton D Kilts; Charles B Nemeroff; Mark M Goodman
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

7.  The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.

Authors:  Thomas Vanicek; Marie Spies; Christina Rami-Mark; Markus Savli; Anna Höflich; Georg S Kranz; Andreas Hahn; Alexandra Kutzelnigg; Tatjana Traub-Weidinger; Markus Mitterhauser; Wolfgang Wadsak; Marcus Hacker; Nora D Volkow; Siegfried Kasper; Rupert Lanzenberger
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.